🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to evaluate the synergistic anti-tumor effect of C...
Status
Unknown
Location
Jiege Huo
Start Date
2015-06
Trial ID
NCT02510118
Treatments Being Tested
Our study is a prospective, randomized phase II clinical trial, to compare ...
Status
Unknown
Location
Dept. Breast Surgery, PUMCH
Start Date
2014-01
Trial ID
NCT02838238
Treatments Being Tested
Gastric/GEJ adenocarcinoma, which is one of the major leading causes of can...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-12-25
Trial ID
NCT06177041
Treatments Being Tested
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
This study will evaluate the efficacy and safety of atezolizumab plus chemo...
Status
Completed
Location
Florida Cancer Specialists - Fort Myers (Broadway)
Start Date
2018-01-11
Trial ID
NCT03371017
Treatments Being Tested
The purpose of this study is to estimate overall survival of Sintilimab+ ox...
Status
Completed
Location
The Fifth Medical Center,Chinese PLA General Hospital
Start Date
2018-12-19
Trial ID
NCT03745170
Treatments Being Tested
This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Status
Unknown
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00262067
Treatments Being Tested
This study will compare the anti-tumor efficacy of apricoxib and lapatinib/...
Status
Terminated
Location
Arizona Clinical Research Center
Start Date
2008-04
Trial ID
NCT00657137
Treatments Being Tested
This is an exploratory phase 2, randomized placebo-controlled trial with st...
Status
Completed
Location
AOI Pharmaceuticals Investigative Site
Start Date
2005-08
Trial ID
NCT00398879
Treatments Being Tested
This study aims to evaluate the efficacy and safety of camrelizumab in comb...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2024-03
Trial ID
NCT06313463
Treatments Being Tested